Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Date:3/3/2010

303)d (333)d (684)g (177)g - (665)f Depreciation and amortiz- ation 8,406 (7,612)e 794 8,421 (7,460)e 961 Write-down of assets held for sale 3,090 (3,090)i - 1,283 (1,283)i - Write-down of goodwill - - - 50,285 (50,285)i - ------------------------------------------------------------------------- 71,577 (13,089) 58,488 115,489 (62,224) 53,265 ------------------------------------------------------------------------- Operating income (loss) (8,016) 13,036 5,020 (53,407) 61,872 8,465 ------------------------------------------------------------------------- Other income (expenses): Foreign exchange (loss) gain (385) 385 h - (1,032) 1,032 h - Investment and other income (loss) 304 288 j 92 (498) 544 j 46 (500)c Interest expense on long-term debt (9,068) 712 f (8,356) (10,639) 559 f (10,080) Write-down/ loss on investments - - - (10,964) 10,964 i - Write-down and other deferred financing charges - - - (3,000) 3,000 f - ------------------------------------------------------------------------- (9,149) 885 (8,264) (26,133) 16,099 (10,034) ------------------------------------------------------------------------- (Loss) income before income taxes (17,165) 13,921 (3,244) (79,540) 77,971 (1,569) Income tax expense (recovery) (1,532) 3,016 l 1,484 (2,577
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015 CytomX, a biotechnology company developing Probody™ ... Sean McCarthy , D. Phil., chief executive officer, ... and Company 35 th Annual Health Care Conference ... will take place at 4 p.m. EST on Monday, ... Therapeutics develops Probody™ therapeutics for the treatment of cancer. ...
(Date:2/26/2015)... Phosphate Therapeutics, today announces ... pivotal trial of PT20 in subjects with hyperphosphataemia ... has completed as the pre-specified number of randomisations ... leading UK-based scientists from the Medical Research Council ... novel phosphate binder that is based on proprietary ...
(Date:2/25/2015)... Feb. 25, 2015 Today, BioMed Realty Trust, ... including a number of promotions and additions to its ... strategy to increase shareholder returns through strategic investments in ... care industry and the innovation sector. ... Griffin is leaving his role as President and ...
(Date:2/25/2015)... 2015 Salt Lake Community ... from the National Science Foundation’s Scholarships ... , The Foundation’s program supports scholarships for academically ... to enter the workforce following completion of an ... Institutions throughout the U.S. annually vie for grants ...
Breaking Biology Technology:Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 2BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 3BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 4SLCC Receives $600K National Science Foundation Grant 2
... , , , ... keystone of indirect land use study - Searchinger et al. ... John Mathews and Dr. Hao Tan, researchers from Macquarie University in Sydney, ... revealed that the framework used was inappropriate in that it started with ...
... from the Chinese Academy of Sciences and Nano-Science Center, ... nanoscale electric contacts out of organic and inorganic nanowires. ... like Mikado sticks and coupled several contacts together in ... prototype computer electronics on the nanoscale. ...
... Andrea Armani and Ellis Meng, Both from Viterbi School for ... in September , , LOS ANGELES and ... today announced that two faculty members from the USC Viterbi School ... as some of the world,s top innovators under the age of ...
Cached Biology Technology:Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking: 'Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for Rule-making.' 2Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking: 'Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for Rule-making.' 3New material for nanoscale computer chips 2Two University of Southern California Innovators Recognized by Technology Review's Prestigious TR35 Listing of the World's Top Young Innovators for 2009 2Two University of Southern California Innovators Recognized by Technology Review's Prestigious TR35 Listing of the World's Top Young Innovators for 2009 3Two University of Southern California Innovators Recognized by Technology Review's Prestigious TR35 Listing of the World's Top Young Innovators for 2009 4Two University of Southern California Innovators Recognized by Technology Review's Prestigious TR35 Listing of the World's Top Young Innovators for 2009 5
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... , January 28, 2015 ... Analysis, Size And Segment Forecasts To 2020 has Been ... IR camera market is expected to reach USD 5.10 ... Grand View Research, Inc. IR cameras help identify the ... are expected to witness surging demand in medical imaging ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... How long your parents lived does not affect how long you ... determines how old you will get, reveals research from the University ... . It is often assumed that people with parents who ... a grand old age themselves. "But that,s just not true ...
... A team of applied physicists at Harvard,s School ... have demonstrated the formation of semipermeable vesicles from inorganic ... the journal Soft Matter, shows that clay ... complex organic molecules. The authors say the discovery ...
... contains antioxidants which may be beneficial to health. New research ... demonstrates that chocolate is a rich source of antioxidants ... When researchers at the Hershey Center for Health & ... powders they found that, gram per gram, there was more ...
Cached Biology News:Lifestyle affects life expectancy more than genetics 2Clay-armored bubbles may have formed first protocells 2
QPRT Antibody...
Protein Marker Detection Pack contains biotinylate...
Mouse monoclonal [4C4] to Y14 ( Abpromise for all tested applications). entrezGeneID: 9939 SwissProtID: Q9Y5S9...
JMJD2B Antibody...
Biology Products: